# FDA 483 - ALS Group USA, Corp - January 25, 2019

Source: https://www.globalkeysolutions.net/records/483/als-group-usa-corp/0724040e-144f-4a1a-9490-c9fa043695b0

> FDA 483 for ALS Group USA, Corp on January 25, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: ALS Group USA, Corp
- Inspection Date: 2019-01-25
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - 2023-06-05](https://www.globalkeysolutions.net/records/483/als-group-usa-corp/7b63f612-3502-489d-bfad-d05724259da2)
- [483 - 2023-06-05](https://www.globalkeysolutions.net/records/483/als-group-usa-corp/12cbf742-bcf6-4395-8880-3d402ca40dd9)

## Related Officers

- [Carrie A. Hughes](https://www.globalkeysolutions.net/people/carrie-a-hughes/099d1128-0ba9-4e7a-a0d2-8c10083811c9)
- [Pharmaceutical investigator](https://www.globalkeysolutions.net/people/bryan-a-galvez/d1e52abc-5b56-4ffb-af22-90e6733fb73a)

Company: https://www.globalkeysolutions.net/companies/als-group-usa-corp/6d3305d4-76a4-4d57-8ed6-1e636d486309

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6